A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal allergies
- Registry ID
- EUCTR2015-004885-27
- Source registry
- EUCTR
- Phase
- PHASE4
- Sponsor
- GlaxoSmithKline Research & Development Ltd
- Last update
- 2026-08-16
Conditions
- Seasonal allergic rhinitis (SAR)
Summary
The primary objective of this study was to demonstrate that FFNS provides superior nighttime symptom relief over fexofenadine.
View on source registry